Nervous System – Cell Power

Disorders or Diseases of Nervous System

The following section lists major devlopment along the innovative drug route.

Click horizontal tabs above for more information.

Company
* product

IND

Phase I

Phase II

Phase III

iRegene
*NouvNeu001

iRegene
*NouvNeu003
*early-onset PD

NuwaCell
*NCR201

UniXell
*UX-DA001
*autologous

UniXell
*UX-DA002
*allogeneic

XellSmart
*XS411
*allogeneic

Company
* product

IND

Phase I

Phase II

Phase III

XellSmart
*XS228
*FDA orphan drug disignation

Darwin Biotech
*MSC-derived protein complex

Company
* product

IND

Phase I

Phase II

Phase III

Hopstem Biotech
*hNPC01
*FDA granted phase 2

Jiuzhitang Maker
*Bone-marrow MSC

Company
* product

IND

Phase I

Phase II

Phase III

XellSmart
*XS228
*FDA orphan drug disignation

Novabio Therapeutics
*Regulaory T cells

Company
* product

IND

Phase I

Phase II

Phase III

Hopstem Biotech
*hNPC01

???
*

Company
* product

IND

Phase I

Phase II

Phase III

Hopstem Biotech
*hNPC01

???
*

The following section lists major development along the innovatie biomedical technology route.

Click horizontal tabs above for more information.

Hospitals

Clinical Study

Approved

Shanghai Eastern Hospital (Shanghai)

Capital Medical University Xuanwu Hospital (Beijing)

Zhengzhou University First Affiliated Hospital (Zhengzhou)

Hospitals / Medical Centers

Clinical Study

Approved

Shanghai Tongji Hospital (Shanghai)

West China Hospital of Sichuan University (Chengdu)

Xi’an High-tech Hospital (Xi’an)

Xiangya Hospital of Central South University (Changsa)

Hospitals

Clinical Study

Approved

Peking Union Medical College Hospital (Beijing)

Shanghai Renji Hospital (Shanghai)

Dalian Medical University First Affiliated Hospital

Third Affiliated Hospital of Sun Yat-sen University (Guangzhou)

Hospitals

Clinical Study

Approved

Shanghai Eastern Hospital (Shanghai)

West China Hospital of Sichuan University (Chengdu)

Hospitals

Clinical Study

Approved

818令后没有；大连医科大学附属第一医院、安徽医科大学第一附属医院没继续。

Hospitals

Clinical Study

Approved

818令后没有；

End

This is a page dedicated to cell therapies for nervous system disorders or diseases.

They following section lists major onging devlopment along the innovative drug route.

This section lists major onging devlopment along the innovative drug route.

Company
* product

IND

Phase I

Phase II

Phase III

iRegene
*NouvNeu001

iRegene
*NouvNeu003
*early-onset PD

NuwaCell
*NCR201

UniXell
*UX-DA001
*autologous

UniXell
*UX-DA002
*allogeneic

XellSmart
*XS411
*allogeneic

Company
* product

IND

Phase I

Phase II

Phase III

XellSmart
*XS228
*FDA orphan drug disignation

Darwin Biotech
*MSC-derived protein complex

Company
* product

IND

Phase I

Phase II

Phase III

Hopstem Biotech
*hNPC01
*FDA granted phase 2

Jiuzhitang Maker
*Bone-marrow MSC

Company
* product

IND

Phase I

Phase II

Phase III

XellSmart
*XS228
*FDA orphan drug disignation

Novabio Therapeutics
*Regulaory T cells

Company
* product

IND

Phase I

Phase II

Phase III

Hopstem Biotech
*hNPC01

???
*

Company
* product

IND

Phase I

Phase II

Phase III

Hopstem Biotech
*hNPC01

???
*

They following section lists major development along the innovatie biomedical technology route.

This section lists major ongoing development along the innovatie biomedical technology route.

Hospitals

Clinical Study

Approved

Shanghai Eastern Hospital (Shanghai)

Capital Medical University Xuanwu Hospital (Beijing)

Zhengzhou University First Affiliated Hospital (Zhengzhou)

Hospitals / Medical Centers

Clinical Study

Approved

Shanghai Tongji Hospital (Shanghai)

West China Hospital of Sichuan University (Chengdu)

Xi’an High-tech Hospital (Xi’an)

Xiangya Hospital of Central South University (Changsa)

Hospitals

Clinical Study

Approved

Peking Union Medical College Hospital (Beijing)

Shanghai Renji Hospital (Shanghai)

Dalian Medical University First Affiliated Hospital

Third Affiliated Hospital of Sun Yat-sen University (Guangzhou)

Hospitals

Clinical Study

Approved

Shanghai Eastern Hospital (Shanghai)

West China Hospital of Sichuan University (Chengdu)

Hospitals

Clinical Study

Approved

818令后没有；大连医科大学附属第一医院、安徽医科大学第一附属医院没继续。

Disorders or Diseases of Nervous System

The following section lists major devlopment along the innovative drug route.

The following section lists major development along the innovatie biomedical technology route.

End

This is a page dedicated to cell therapies for nervous system disorders or diseases.

They following section lists major onging devlopment along the innovative drug route.

They following section lists major development along the innovatie biomedical technology route.

Call us now, and our team will assist you immediately!

+01 859 048 9

Send us a message, and our team will get back to you within 24 hours to help!

mail@yoursite.com